A Virtual Lab That Turns Up Real Life Drugs

IN THEIR NEVER ENDING search for new drug candidates, pharmaceutical companies are increasingly turning to "combinatorial" chemistry. The idea is to combine molecular building blocks in different ways, thus synthesizing thousands of new chemicals. Each molecule can then be tested for drug-like effects.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.